Latest news

• Encouraging data for Roche flu drug ahead of FDA decision

  65 years of age or older, or those who have conditions such as asthma, chronic lung disease, morbid obesity, or heart disease.

• Roche’s Tamiflu successor hits the mark in complicated flu

  with other illnesses such as asthma, chronic lung disease, diabetes, or heart disease. ... Flu remains a major cause of death worldwide, leading to severe disease in 3 to 5 million people every year and causing around 650, 000 deaths.

• AZ makes gene therapy move with 4DMT alliance

  AstraZeneca’s push into genetic therapies has stepped up a gear, thanks to a collaboration with 4D Molecular Therapeutics on a new project in chronic lung disease. ... chronic lung disease, particularly in areas of high unmet need.

• Harnessing clinical data

  The drugmaker said in January that it would use 2net for observational trials, using smartphones to collect biometric data from patients with chronic lung disease, while Roche is also planning to ... link to the system and Walgreens Boots Alliance has

• Hints of recovery at GSK as group sales climb

  shingles vaccine, as well as experimental drugs for chronic lung disease and asthma, anaemia and heart disease.